NCT07458542 2026-03-09
Effectiveness and Safety of ONUREG (Oral Azacitidine) in Chinese Patients With Acute Myeloid Leukemia
Bristol-Myers Squibb
Active not recruiting
Clinical Trials
4 trialsNCT06565975 2026-02-12
RELION
Bristol-Myers Squibb
Completed
NCT06073769 2024-11-06
A Post-Marketing Surveillance Study to Assess the Safety of Oral Azacitidine Maintenance Therapy in Korean Patients With Acute Myeloid Leukemia
Bristol-Myers Squibb
Recruiting
NCT04230564 2023-06-07
Acute Myeloid Leukemia Real World Treatment Patterns
Pfizer
Withdrawn